Status:
RECRUITING
Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Postpartum. Hypertension
Lead Sponsor:
Sohag University
Conditions:
Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension
Eligibility:
FEMALE
18-45 years
Brief Summary
This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping \& Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo)...
Eligibility Criteria
Inclusion
- Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals
Exclusion
- All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents
Key Trial Info
Start Date :
June 25 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06500351
Start Date
June 25 2024
End Date
September 1 2025
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university hosoital
Sohag, Egypt